Scientists have shown how a promising viral therapy that delivers a double blow to cancer can sneak up on tumors by hitching a ride on blood cells.
“By piggybacking on blood cells, the virus is managing to hide from the body’s natural immune response and reach its target intact. This could be hugely significant for the uptake of viral therapies like this in clinical practice,” says University of Leeds researcher Professor Alan Melcher.
Full story at Futurity.
More research news from top universities.
Photo credit: U. Leeds